Farmed Turkey Welfare and Health Challenges

Commercial turkey production involves birds selectively bred for extreme growth rates that create serious health and welfare problems similar to those seen in broiler chickens.

Key Facts

Commercial turkeys have been selected for breast muscle development to the extent that natural mating is impossible in most breeds.
Leg disorders, cardiovascular disease, and metabolic conditions are common welfare problems in commercial turkey breeds.
Most commercial turkeys are slaughtered at 12-24 weeks — well before the lifespan issues of natural ageing become relevant, but during a period of metabolic strain.
Slower-growing traditional breed turkeys show substantially lower rates of health problems and better welfare indicators.
Stocking density in turkey production directly affects litter quality, ammonia levels, and foot pad dermatitis rates.

Welfare Considerations

Commercial turkey welfare faces the same structural challenge as broiler chicken production: selection for extreme growth rates has created birds whose physiology is incompatible with welfare. Leg disorders, cardiovascular strain, and the inability to mate naturally are not individual misfortunes — they are predictable outcomes of breeding priorities that have consistently prioritized productive efficiency over animal health. Welfare improvement requires breed change, as management improvements alone cannot address genetic health compromise.

What You Can Do

Choose turkey products from traditional or slower-growing breed operations for significantly better welfare outcomes.
Support the Better Chicken Commitment and equivalent turkey welfare initiatives that require breed welfare standards.
Reduce turkey consumption and replace with plant-based alternatives to reduce demand for intensive systems.
Support campaigns for mandatory breed welfare criteria in turkey assurance schemes and marketing standards.